NGM Biopharmaceuticals, Inc.
NASDAQ:NGM
1.54 (USD) • At close April 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -142.375 | -162.667 | -120.335 | -102.487 | -42.795 | -0.493 | -14.159 | -6.922 |
| Depreciation & Amortization
| 2.221 | 4.035 | 6.089 | 6.555 | 7.605 | 7.223 | 6.441 | 3.534 |
| Deferred Income Tax
| 4.977 | 0 | 3.514 | -0.128 | -1.123 | -0.799 | 0.244 | 1.086 |
| Stock Based Compensation
| 28.719 | 32.383 | 26.242 | 15.651 | 12.981 | 9.962 | 7.717 | 6.018 |
| Change In Working Capital
| -18.376 | -20.712 | 4.208 | -3.7 | -17.94 | -23.581 | -17.738 | -2.512 |
| Accounts Receivables
| 7.522 | -2.635 | -3.112 | 4.873 | -1.537 | 0 | 0 | 0 |
| Inventory
| 0 | 2.635 | 3.112 | -4.873 | 1.537 | 0 | 0 | 0 |
| Accounts Payables
| -4.977 | 3.207 | -4.417 | 0.91 | 3.642 | 3.484 | -4.23 | 2.75 |
| Other Working Capital
| -20.921 | -23.919 | 8.625 | -4.61 | -21.582 | -27.065 | -13.508 | -5.262 |
| Other Non Cash Items
| -7.368 | 2.522 | 7.053 | 0.613 | 0.098 | 0.091 | 0.082 | 0.065 |
| Operating Cash Flow
| -132.202 | -144.439 | -73.229 | -83.496 | -41.174 | -7.597 | -17.413 | 1.269 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -1.252 | -1.858 | -1.684 | -1.879 | -3.489 | -5.844 | -6.422 | -24.804 |
| Acquisitions Net
| 0 | -16.18 | 69.966 | 49.119 | -52.212 | 0 | 0 | 0 |
| Purchases Of Investments
| -105.431 | -272.857 | -293.466 | -177.655 | -134.306 | -133.609 | -217.291 | -132.602 |
| Sales Maturities Of Investments
| 220.97 | 289.037 | 223.5 | 128.536 | 186.518 | 178.182 | 220.917 | 92.639 |
| Other Investing Activites
| 0 | 16.18 | -69.966 | -49.119 | 52.212 | 0 | 0 | 0.06 |
| Investing Cash Flow
| 114.287 | 14.322 | -71.65 | -50.998 | 48.723 | 38.729 | -2.796 | -64.707 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | -49.446 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 1.775 | 2.984 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -0.185 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.775 | 51.249 | 149.657 | 35.538 | 180.751 | 0.383 | 0.339 | 0.231 |
| Financing Cash Flow
| 1.775 | 54.233 | 149.657 | 35.538 | 180.751 | 0.198 | 0.339 | 0.231 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 1.499 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -14.641 | -75.884 | 4.778 | -98.956 | 188.3 | 31.33 | -19.87 | -63.207 |
| Cash At End Of Period
| 58.815 | 77.41 | 153.294 | 148.516 | 247.472 | 59.172 | 25.593 | 45.463 |